Influence of loop diuretics on denosumab-induced hypocalcaemia in osteoporosis: a retrospective observational analysis
Authors:
Open Access
- 27 September 2024
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Health Care and Sciences
- Vol. 10 (1) , 1-9
Abstract
Background: We examined whether denosumab-induced hypocalcaemia is evident in osteoporosis when given loop diuretics that promote urinary calcium excretion. Methods: Japanese Spontaneous Adverse Drug Event Reports was analyzed to examine signals for denosumab-induced hypocalcaemia co-administered loop diuretics. We retrospectively included osteoporotic patients to detect predictors for denosumab-induced hypocalcaemia (corrected calcium level < 8.5 mg/dL) using multivariate logistic regression analysis. We compared differences in corrected calcium levels (ΔCa = nadir-baseline). Results: A significant signal for hypocalcaemia was detected (Reporting odds ratio = 865.8, 95% confidence interval [95% CI]: 596.8 to 1255.9, p < 0.0001). Among 164 patients (hypocalcaemia, 12%), loop diuretics have a significant association with hypocalcaemia (odds ratio [OR] = 6.410, 95% CI: 1.005 to 40.90, p = 0.0494). However, hypocalcaemia was found to be lower in high corrected calcium levels at baseline (OR = 0.032, 95% CI: 0.005 to 0.209, p < 0.0001) and calcium and vitamin D supplementation (OR = 0.285, 95% CI: 0.094 to 0.868, p = 0.0270). In the non-hypocalcaemia, ΔCa decreased significantly in the denosumab plus loop diuretics than in the denosumab alone (-0.9 [-1.3 to -0.7] mg/dL vs. -0.5 [-0.8 to -0.3] mg/dL, p = 0.0156). However, ΔCa remained comparable in the hypocalcaemia despite loop diuretics co-administration (-1.0 [-1.2 to -0.8] mg/dL vs. -0.8 [-1.5 to -0.7] mg/dL, p = 0.7904). Conclusions: Loop diuretics may predispose to developing denosumab-induced hypocalcaemia.Keywords
This publication has 30 references indexed in Scilit:
- Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2009
- Revised Equations for Estimated GFR From Serum Creatinine in JapanAmerican Journal of Kidney Diseases, 2009
- Effects of Denosumab on Bone Mineral Density and Bone Turnover in Postmenopausal WomenThe Journal of Clinical Endocrinology & Metabolism, 2008
- Dose‐effect relations of loop‐ and thiazide‐diuretics on calcium homeostasis: a randomized, double‐blinded Latin‐square multiple cross‐over study in postmenopausal osteopenic womenEuropean Journal of Clinical Investigation, 2003
- Hypomagnesemia and Concurrent Acid–Base and Electrolyte Abnormalities in Patients with Congestive Heart FailureEuropean Journal of Heart Failure, 2002
- Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure*Clinical Pharmacology & Therapeutics, 1995
- Mechanism of chronic hypercalciuria with furosemide: increased calcium absorptionAmerican Journal of Physiology-Renal Physiology, 1986
- Clinical and pharmacological investigations of the new saluretic azosemidEuropean Journal of Clinical Pharmacology, 1978
- Increased Serum Calcium Levels Induced by FurosemideSouthern Medical Journal, 1977
- Interpretation of Serum Calcium in Patients with Abnormal Serum ProteinsBMJ, 1973